ZAPONEX

This brand name is authorized in Netherlands, United Kingdom

Active ingredients

The drug ZAPONEX contains one active pharmaceutical ingredient (API):

1 Clozapine
UNII J60AR2IKIC - CLOZAPINE

Clozapine has been shown to be an antipsychotic agent that is different from classic antipsychotics. Clozapine has potent anti-alpha-adrenergic, anticholinergic, antihistaminic, and arousal-reaction-inhibiting effects. It has also been shown to possess antiserotoninergic properties.

Read about Clozapine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZAPONEX Orodispersible tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AH02 Clozapine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 101219, 101222, 376873, 376876, 376880, 376884, 376889, 88391, 88408
Country: NL Z-Index G-Standaard, PRK Identifier(s): 201413, 201421, 201448, 201456, 201480

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.